The FTC pointed to evidence of harm gathered during a year-long assessment of the proposed merger. The data, the agency argued, showed that the competitive and consumer harm the merger would create would not “be outweighed by any potential benefits of the merger, nor would it be eliminated or effectively mitigated by regulating the combined entity’s post-merger conduct.”
A representative from the agency voiced similar concerns during a public hearing Nov. 21 in Tennessee. It was the third time the agency publicly declared its opposition to the merger.
The Southwest Virginia Health Authority approved the merger earlier this month.
State officials in Tennessee have until Jan. 12 to issue a decision.
More articles on transactions and partnerships:
OCH Health System to purchase Oklahoma clinic
4 recent hospital transactions and partnerships
Radiology Partners adds 16 sites, expands partnerships in Midwest, Texas
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
